Current and historical daily PE Ratio for Intravenous Infusions Ltd (
XGHA:IIL
) from 2015 to Jun 20 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Intravenous Infusions stock (XGHA:IIL) PE ratio as of Jun 20 2024 is 9999.
More Details
Intravenous Infusions Ltd (XGHA:IIL) PE Ratio (TTM) Chart
Intravenous Infusions Ltd (XGHA:IIL) PE Ratio (TTM) Historical Data
View and export this data going back to 2015. Start your Free Trial
Total 0
- 1
Intravenous Infusions PE Ratio (TTM) Historical Data | |||
---|---|---|---|
Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
Intravenous Infusions Ltd (XGHA:IIL) PE Ratio (TTM) Comparison
Company | Market Cap(Mil) | PE Ratio (TTM) |
---|
Business Description
Business Description
Intravenous Infusions Ltd
ISIN : GH0000001258
Share Class Description:
XGHA:IIL: Ordinary SharesCompare
Compare
Traded in other countries / regions
IIL.Ghana IPO Date
2015-04-08Description
Intravenous Infusions Ltd engages in the production of intravenous infusion and small-volume injectables for therapeutic purposes. The product categories are IV fluids, giving sets, and small-volume injectables. The company earns a majority of its revenue from IV fluids. Some of the IV fluids are sodium chloride solutions, dextrose solutions, dextrose saline solutions, and dextran solutions. Small-volume injectables include pethidine injection, magnesium sulphate injection, and quinine injection. Giving sets include plain giving sets, and blood giving sets.